ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 92 filers reported holding ORIC PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 6.67 and the average weighting 0.6%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 602,272 | $3,643,746 | 14.84% |
| Column Group LLC | 3,568,181 | $21,587,495 | 14.33% |
| Nextech Invest Ltd. | 4,285,714 | $25,928,570 | 7.86% |
| Prosight Management, LP | 2,579,802 | $15,607,802 | 4.95% |
| Invus Financial Advisors, LLC | 1,007,575 | $6,095,829 | 3.82% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,123,345 | $6,796,237 | 2.06% |
| VR Adviser, LLC | 2,142,856 | $12,964,279 | 1.36% |
| Altium Capital Management LP | 418,706 | $2,533,171 | 1.32% |
| Euclidean Capital LLC | 1,978,820 | $11,971,862 | 1.31% |
| Frazier Life Sciences Management, L.P. | 2,142,855 | $12,964,273 | 0.86% |
| EcoR1 Capital, LLC | 3,418,068 | $20,679,311 | 0.70% |
| Monaco Asset Management SAM | 384,793 | $2,327,998 | 0.69% |
| Boxer Capital, LLC | 1,732,571 | $10,482,055 | 0.56% |
| Vivo Capital, LLC | 777,944 | $4,706,561 | 0.52% |
| Octagon Capital Advisors LP | 204,500 | $1,237,225 | 0.19% |
| ArrowMark Colorado Holdings LLC | 1,649,956 | $9,982,234 | 0.12% |
| Orbimed Advisors | 893,668 | $5,406,691 | 0.12% |
| UBS OCONNOR LLC | 351,502 | $2,126,587 | 0.05% |
| Atom Investors LP | 34,241 | $207,158 | 0.05% |
| Alkeon Capital Management | 3,479,289 | $21,049,699 | 0.04% |
External links
This page lists ORIC PHARMACEUTICALS INC's shareholders in Q3 2023. To view ORIC PHARMACEUTICALS INC's shareholder history, click here.